Prosecution Insights
Prosecution Insights
Technology area: Chemistry & Materials
2 pending office actions • 1 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready
Centro De Retina Médica Y Quirúrgica S C is currently managing 2 pending office actions in the Chemistry & Materials technology area. These 2 actions are assigned to 2 distinct examiners, meaning each examiner is handling one matter. Both of these matters are housed within 1 distinct art unit, indicating a very high level of technical and organizational concentration. The fact that 2 pending office actions are located in 1 distinct art unit suggests that the Chemistry & Materials filings are highly specialized.
KETCHAM, HANNAH ELIZABETH is the busiest examiner for this portfolio, with 1 pending office action. This 1 action constitutes half of the 2 pending office actions currently active for the company. Because there are 2 distinct examiners, KETCHAM, HANNAH ELIZABETH shares the workload equally with one other examiner within the same art unit. Practitioners can focus their efforts on the specific practices of this 1 distinct art unit while managing the 2 distinct examiners. The 1 pending office action under KETCHAM, HANNAH ELIZABETH is a critical component of this focused prosecution strategy.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 2 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| KETCHAM, HANNAH ELIZABETH | 1 | — | — |
| LANGEL, WAYNE A | 1 | 78.4% | +23.2% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18267475 | METHOD AND CHEMICAL FORMULATION FOR TREATING CONTAMINATED MEDICAL WASTE | KETCHAM, HANNAH ELIZABETH | — |
| 18015794 | PERACETIC ACID-BASED FORMULATION ASSOCIATED WITH A GRINDING PROCESS, THE COMBINATION OF WHICH TRANSFORMS CULTURES AND STRAINS OF BIOHAZARDOUS INFECTIOUS WASTE GENERATED IN THE PRODUCTION OF VACCINES IN OVO INTO RAW MATERIAL FOR THE PREPARATION OF HIGH-PROTEIN COMPOSTS | LANGEL, WAYNE A | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18015794 | PERACETIC ACID-BASED FORMULATION ASSOCIATED WITH A GRINDING PROCESS, THE COMBINATION OF WHICH TRANSFORMS CULTURES AND STRAINS OF BIOHAZARDOUS INFECTIOUS WASTE GENERATED IN THE PRODUCTION OF VACCINES IN OVO INTO RAW MATERIAL FOR THE PREPARATION OF HIGH-PROTEIN COMPOSTS | LANGEL, WAYNE A | — |
| Art Unit | Apps |
|---|---|
| 1736 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18267475 | METHOD AND CHEMICAL FORMULATION FOR TREATING CONTAMINATED MEDICAL WASTE | KETCHAM, HANNAH ELIZABETH | — | §103§112 | Non-Final OA | — | Pending | Feb 09, 2024 |
| 18015794 | PERACETIC ACID-BASED FORMULATION ASSOCIATED WITH A GRINDING PROCESS, THE COMBINATION OF WHICH TRANSFORMS CULTURES AND STRAINS OF BIOHAZARDOUS INFECTIOUS WASTE GENERATED IN THE PRODUCTION OF VACCINES IN OVO INTO RAW MATERIAL FOR THE PREPARATION OF HIGH-PROTEIN COMPOSTS | LANGEL, WAYNE A | 1736 | §103§112Other | Non-Final OA | — | Pending | Jan 12, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial